Synthesis and characterization of violurate-based Mn(II) and Cu(II) complexes nano-crystallites as DNA-binders and therapeutics agents against SARS-CoV-2 virus

[1]  A. Ramadan,et al.  Quercetin - Based Rhodium(III) Complex: Synthesis, Characterization and Diverse Biological Potentials , 2022, Journal of Molecular Structure.

[2]  Tolga Göktürk,et al.  New trinuclear nickel(II) complexes as potential topoisomerase I/IIα inhibitors: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines , 2022, Chemical Papers.

[3]  Sana Ashiq,et al.  Metal Complexes and Their Potential Therapeutic Role Against COVID-19: Recent Developments in Drug Designing , 2021, Sudan Journal of Medical Sciences.

[4]  M. Ibrahim,et al.  Anionic Ligands Tune the Structural and Catalytic Properties of Quinoxaline-Based Copper(II) Complexes as Mimetics of Copper-Containing Oxidase Protein , 2021, Journal of Molecular Structure.

[5]  G. Mohamed,et al.  Synthesis, spectroscopic characterization, and thermal studies of novel Schiff base complexes: theoretical simulation studies on coronavirus (COVID-19) using molecular docking , 2021, Journal of the Iranian Chemical Society.

[6]  M. Kurup,et al.  A novel manganese(II) bisthiocarbohydrazone complex: Crystal structures, Hirshfeld surface analysis, DFT and molecular docking study with SARS-CoV-2 , 2021, Journal of molecular structure.

[7]  Cemil Can Saylan,et al.  The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2 , 2021, Journal of Molecular Structure.

[8]  M. Nawaz,et al.  An in vitro antiviral activity of iodine complexes against SARS-CoV-2 , 2021, Archives of Microbiology.

[9]  Seth M. Cohen,et al.  Metal Complexes as Antiviral Agents for SARS‐CoV‐2 , 2021, Chembiochem : a European journal of chemical biology.

[10]  Seth M. Cohen,et al.  Metal Complexes for Therapeutic Applications. , 2021, Trends in chemistry.

[11]  M. Ibrahim,et al.  Corrigendum to synthesis and structural characterization of pyridine-based Mn(III), Fe(III), and Co(III) complexes as SOD mimics and BSA binding studies , 2021 .

[12]  M. Ibrahim,et al.  Synthesis and Structural Characterization of Pyridine-based Mn(III), Fe(III), and Co(III) Complexes as SOD Mimics and BSA Binding Studies , 2021 .

[13]  Manos C. Vlasiou,et al.  Screening possible drug molecules for Covid-19. The example of vanadium (III/IV/V) complex molecules with computational chemistry and molecular docking , 2020, Computational Toxicology.

[14]  R. Karvembu,et al.  Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2 , 2020, Inorganic chemistry.

[15]  P. Sadler,et al.  Metallodrugs are unique: opportunities and challenges of discovery and development , 2020, Chemical science.

[16]  Chunlong Ma,et al.  Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L , 2020, Science Advances.

[17]  P. Corbi,et al.  What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks. , 2020, Dalton transactions.

[18]  J. Chan,et al.  Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters , 2020, Nature Microbiology.

[19]  L. Messori,et al.  Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs , 2020, Expert opinion on drug discovery.

[20]  I. Ott,et al.  Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike‐ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics** , 2020, Chemistry.

[21]  J. Karges.  Combining Inorganic Chemistry and Biology: The Underestimated Potential of Metal Complexes in Medicine , 2020, Chembiochem : a European journal of chemical biology.

[22]  G. Hummer,et al.  Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity , 2020, Nature.

[23]  Md. Jawaid Akhtar.  COVID19 inhibitors: A prospective therapeutics , 2020, Bioorganic Chemistry.

[24]  H. Rothan,et al.  The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells , 2020, Virology.

[25]  L. Messori,et al.  A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin , 2020, ACS medicinal chemistry letters.

[26]  M. Ibrahim,et al.  Synthesis and spectroscopic characterization of ternary copper(ii) complexes containing nitrogen and oxygen donors as functional mimics of catechol oxidase and phenoxazinone synthase , 2020 .

[27]  Jonathan F. Swanson,et al.  COVID‐19: A review of therapeutics under investigation , 2020, Journal of the American College of Emergency Physicians open.

[28]  Qingbo Xu,et al.  Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 , 2020, Circulation research.

[29]  H. Rothan,et al.  The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells , 2020, bioRxiv.

[30]  Guangdi Li,et al.  Therapeutic options for the 2019 novel coronavirus (2019-nCoV) , 2020, Nature Reviews Drug Discovery.

[31]  W. Liu,et al.  Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV , 2020, Chembiochem : a European journal of chemical biology.

[32]  Qianyun Liu,et al.  Emerging coronaviruses: Genome structure, replication, and pathogenesis , 2020, Journal of medical virology.

[33]  G. Gasser,et al.  Classification of Metal-based Drugs According to Their Mechanisms of Action. , 2020, Chem.

[34]  D. Musib,et al.  Transition metal complexes as potential tools against SARS-CoV-2: anin silicoapproach , 2020 .

[35]  Md Saddam Hossain,et al.  Anti-pathogenic Activity of Cu(II) Complexes Incorporating Schiff Bases: A Short Review , 2019 .

[36]  F. Edelmann,et al.  Review: the multicolored coordination chemistry of violurate anions , 2019, Journal of Coordination Chemistry.

[37]  G. Gasser,et al.  Metal Compounds against Neglected Tropical Diseases. , 2018, Chemical reviews.

[38]  S. Arulantony,et al.  SYNTHESIS, SPECTRAL CHARACTERIZATION OF SCHIFF BASE COMPLEXES BASED ON PYRIMIDINE MOIETY WITH MOLECULAR DOCKING WITH BIOMOLECULES , 2018 .

[39]  W. Berger,et al.  Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development. , 2018, Chemical Society reviews.

[40]  S. Radulović,et al.  New 4'-(4-chlorophenyl)-2,2':6',2″-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA/BSA and cytotoxicity studies. , 2017, Journal of inorganic biochemistry.

[41]  U. Baig,et al.  Ferroquine and its derivatives: New generation of antimalarial agents , 2015, European Journal of Medicinal Chemistry.

[42]  Chris Orvig,et al.  Metallodrugs in medicinal inorganic chemistry. , 2014, Chemical reviews.

[43]  I. H. Gubbuk,et al.  Thermal Degradation Behaviour of Ni(II) Complex of 3,4-Methylenedioxaphenylaminoglyoxime , 2013 .

[44]  N. Dharmaraj,et al.  Evaluation of DNA binding, DNA cleavage, protein binding and in vitro cytotoxic activities of bivalent transition metal hydrazone complexes. , 2011, European journal of medicinal chemistry.

[45]  M. Re,et al.  Antiretroviral activity of thiosemicarbazone metal complexes. , 2010, Journal of medicinal chemistry.

[46]  D. Knight,et al.  Cobalt Complexes as Antiviral and Antibacterial Agents , 2010, Pharmaceuticals.

[47]  Asad U. Khan,et al.  Synthesis and spectral characterization of 14- and 16-membered tetraazamacrocyclic Schiff base ligands and their transition metal complexes and a comparative study of interaction of calf thymus DNA with copper(II) complexes. , 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[48]  K. Nakamoto.  Applications in coordination, organometallic, and bioinorganic chemistry , 2009 .

[49]  I. T. Ahmed.  Thermal decomposition study on mixed ligand thymine complexes of divalent nickel(II) with dianions of some dicarboxylic acids , 2007 .

[50]  H. Toma,et al.  Vibrational spectra and theoretical studies of tautomerism and hydrogen bonding in the violuric acid and 6-amino-5-nitrosouracil system , 2007 .

[51]  Kiran Singh,et al.  Synthesis and characterization of cobalt(II), nickel(II), copper(II) and zinc(II) complexes with Schiff base derived from 4-amino-3-mercapto-6-methyl-5-oxo-1,2,4-triazine. , 2007, European journal of medicinal chemistry.

[52]  D. Powell,et al.  Structural variation in copper(I) complexes with pyridylmethylamide ligands: structural analysis with a new four-coordinate geometry index, tau4. , 2007, Dalton transactions.

[53]  Uwe Koch,et al.  2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis. , 2006, Journal of medicinal chemistry.

[54]  N. Raman,et al.  Synthesis, spectral characterization, redox and antimicrobial activity of Schiff base transition metal(II) complexes derived from 4-aminoantipyrine and 3-salicylideneacetylacetone , 2005 .

[55]  Yan-Tuan Li,et al.  Synthesis and ferromagnetically coupled heterodinuclear oxamido-bridged copper(II)–oxovanadium(IV) complexes , 2005 .

[56]  E. De Clercq,et al.  Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir. , 2004, Journal of inorganic biochemistry.

[57]  T. Lu,et al.  Interaction of macrocyclic copper(II) complexes with calf thymus DNA: effects of the side chains of the ligands on the DNA-binding behaviors , 2003 .

[58]  An-Xing Li,et al.  Experimental and theoretical study on DNA-binding and photocleavage properties of chiral complexes Δ- and Λ-[Ru(bpy)2L](L =o-hpip, m-hpip and p-hpip) , 2003 .

[59]  A. Soayed,et al.  SYNTHESIS AND CHARACTERIZATION OF NEW AZOPYRIMIDINE COMPLEXES , 2003 .

[60]  D. Borah,et al.  Kinetic and thermodynamic studies on oxidative desulphurisation of organic sulphur from Indian coal at 50-150°C , 2001 .

[61]  L. Ji,et al.  Interaction of [Ru(dmp)2(dppz)]2+ and [Ru(dmb)2(dppz)]2+ with DNA: effects of the ancillary ligands on the DNA-binding behaviors. , 2001, Inorganic chemistry.

[62]  J. Yakhmi,et al.  An EPR study of spin correlations and existence of ordered and disordered phases in (NBu4)2Mn2[Cu(opba)]3·6DMSO·1H2O , 1997 .

[63]  M. Palaniandavar,et al.  Spectroscopic and voltammetric studies on copper complexes of 2,9-dimethyl-1,10-phenanthrolines bound to calf thymus DNA , 1997 .

[64]  E. De Clercq,et al.  Anti-HIV Activities of Anionic Metalloporphyrins and Related Compounds , 1997 .

[65]  A. Ramadan.  Structural and biological aspects of copper (II) complexes with 2-methyl-3-amino-(3H)-quinazolin-4-one. , 1997, Journal of inorganic biochemistry.

[66]  K. Jeyasubramanian,et al.  Cyclic voltammetric and e.s.r. studies of a tetraaza 14-membered macrocyclic copper(II) complex derived from 3-salicylideneacetylacetone ando-phenylenediamine: stabilization and activation of unusual oxidation states , 1995 .

[67]  J. Chaires,et al.  Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. , 1993, Biochemistry.

[68]  D. Bandyopadhyay,et al.  Hydrazones derived by the condensation of 4-methoxybenzoyl hydrazide with salicylaldehyde, o-hydroxyacetophenone and diacetylmonoxime. As ligands for cobalt (II & III) , 1992 .

[69]  J. Rubim,et al.  Raman and surface‐enhanced Raman scattering of violuric acid and violurate ion adsorbed on a silver electrode , 1991 .

[70]  A. Belal,et al.  The colours of simple salts of the violurate anion , 1991 .

[71]  A. Tossi,et al.  A STUDY OF SOME POLYPYRIDYLRUTHENIUM(II) COMPLEXES AS DNA BINDERS AND PHOTOCLEAVAGE REAGENTS , 1989, Photochemistry and photobiology.

[72]  A. Wolfe,et al.  Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA. , 1987, Biochemistry.

[73]  A. O. Baghlaf,et al.  Linkage isomerism of the oximato group: The characterization of some mono- and binuclear square planar nickel(II) complexes of vicinal oxime-imine ligands☆ , 1985 .

[74]  J. Villafranca,et al.  Interactions of porphyrins with nucleic acids. , 1983, Biochemistry.

[75]  K. Nakamoto.  Infrared and Raman Spectra of Inorganic and Coordination Compounds , 1978 .

[76]  M. Hamelin.  Structure cristalline du violurate de strontium tétrahydraté (C4O4N3H2)2Sr.4H2O , 1976 .

[77]  M. Lacey,et al.  Chelate linkage isomers of (3-Hydroxyimino-4,9-dimethyl-5, 8-diazadodeca-4,9-diene-2,11-dionato) nickel(II) , 1973 .

[78]  C. Guastini,et al.  The crystal and molecular structure of N‐(1‐methyl‐3‐oxobutylidene)‐N'‐(1 ‐methyl‐2‐isonitroso‐3‐oxobutylidene)ethylenediaminecopper(II), CuII(C12H17N3O3) , 1972 .

[79]  W. Geary.  The use of conductivity measurements in organic solvents for the characterisation of coordination compounds , 1971 .

[80]  C. Patel,et al.  Nitrosation of N,N′-ethylenebis-(acetylacetoneimine) complexes of copper (II) and nickel(II) and characterization of the products , 1971 .

[81]  Stuart A. Rice,et al.  Inorganic Electronic Spectroscopy , 1968 .

[82]  G. Schrauzer,et al.  Alkylcobaloximes and Their Relation to Alkylcobalamins , 1966 .

[83]  G. Felsenfeld,et al.  A neighbor-interaction analysis of the hypochromism and spectra of DNA. , 1965, Journal of molecular biology.

[84]  G. Schrauzer,et al.  Chemie der Metall-Koordinations-Verbindungen, II. , 1964 .

[85]  A. W. Coats,et al.  Kinetic Parameters from Thermogravimetric Data , 1964, Nature.

[86]  H. Horowitz,et al.  A New Analysis of Thermogravimetric Traces. , 1963 .

[87]  G. Schrauzer.  Chemie der Metall-Koordinationsverbindungen, I. Reaktion von Bis-dimethylglyoxim-nickel mit Borverbindungen , 1962 .

[88]  J. Marmur.  A procedure for the isolation of deoxyribonucleic acid from micro-organisms , 1961 .

[89]  I. Fidone,et al.  The g-value of S-state Ions , 1959 .